Biopsy versus FDG PET/CT in the initial evaluation of bone marrow involvement in pediatric lymphoma patients

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 38, Issue 8, 2011, Pages 1469-1476

  Cheng, Gang ^a   Chen, Wengen ^b   Chamroonrat, Wichana ^a   Torigian, Drew A ^a   Zhuang, Hongming ^c   Alavi, Abass ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Bone marrow biopsy; FDG PET CT; Lymphoma; Pediatrics

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW BIOPSY; BONE MARROW DISEASE; CANCER PATIENT; CHILD; CHILDHOOD CANCER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FALSE NEGATIVE RESULT; FEMALE; HODGKIN DISEASE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRESCHOOL CHILD; SCHOOL CHILD; SENSITIVITY ANALYSIS;

EID: 85027951834     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-011-1815-z     Document Type: Article

References (21)

1. Wang J, Weiss LM, Chang KL, Slovak ML, Gaal K, Forman SJ, et al. Diagnostic utility of bilateral bone marrow examination: Significance of morphologic and ancillary technique study in malignancy. Cancer 2002;94:1522-31. (Pubitemid 34212647)
2. Kumar R, Maillard I, Schuster SJ, Alavi A. Utility of fluorodeoxyglucose-PET imaging in the management of patients with Hodgkin's and non-Hodgkin's lymphomas. Radiol Clin North Am 2004;42:1083-100. (Pubitemid 39361461)
3. Cheng G, Servaes S, Alavi A, Zhuang H. FDG PET and PET/CT in the management of pediatric lymphoma patients. PET Clin 2008;3:621-34.
4. Paes FM, Kalkanis DG, Sideras PA, Serafini AN. FDG PET/CT of extranodal involvement in non-Hodgkin lymphoma and Hodgkin disease. Radiographics 2010;30:269-91.
5. Moog F, Bangerter M, Kotzerke J, Guhlmann A, Frickhofen N, Reske SN. 18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow. J Clin Oncol 1998;16:603-9. (Pubitemid 28135606)
6. Schaefer NG, Strobel K, Taverna C, Hany TF. Bone involvement in patients with lymphoma: The role of FDG-PET/CT. Eur J Nucl Med Mol Imaging 2007;34:60-7. (Pubitemid 44885555)
7. Muslimani AA, Farag HL, Francis S, Spiro TP, Chaudhry AA, Chan VC, et al. The utility of 18-F-fluorodeoxyglucose positron emission tomography in evaluation of bone marrow involvement by non-Hodgkin lymphoma. Am J Clin Oncol 2008;31:409-12.
8. Fuster D, Chiang S, Andreadis C, Guan L, Zhuang H, Schuster S, et al. Can [18F]fluorodeoxyglucose positron emission tomography imaging complement biopsy results from the iliac crest for the detection of bone marrow involvement in patients with malignant lymphomâ Nucl Med Commun 2006;27:11-5. (Pubitemid 44391834)
9. Pelosi E, Pregno P, Penna D, Deandreis D, Chiappella A, Limerutti G, et al. Role of whole-body [18F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) and conventional techniques in the staging of patients with Hodgkin and aggressive non Hodgkin lymphoma. Radiol Med 2008;113:578-90.
10. Ribrag V, Vanel D, Leboulleux S, Lumbroso J, Couanet D, Bonniaud G, et al. Prospective study of bone marrow infiltration in aggressive lymphoma by three independent methods: Wholebody MRI, PET/CT and bone marrow biopsy. Eur J Radiol 2008;66:325-31. (Pubitemid 351626403)
11. Pakos EE, Fotopoulos AD, Ioannidis JPA. 18F-FDG PET for evaluation of bone marrow infiltration in staging of lymphoma: A meta-analysis. J Nucl Med 2005;46:958-63. (Pubitemid 43733510)
12. Pelosi E, Penna D, Deandreis D, Chiappella A, Skanjeti A, Vitolo U, et al. FDG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non-Hodgkin's lymphoma and its impact on clinical management. Q J Nucl Med Mol Imaging 2008;52:9-16. (Pubitemid 351351040)
13. Moulin-Romsee G, Hindié E, Cuenca X, Brice P, Decaudin D, Bénamor M, et al. (18)F-FDG PET/CT bone/bone marrow findings in Hodgkin's lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging. Eur J Nucl Med Mol Imaging 2010;37:1095-105.
14. Frable WJ. Fine-needle aspiration biopsy: A review. Hum Pathol 1983;14:9-28. (Pubitemid 13186974)
15. Weiss CR, Nour SG, Lewin JS. MR-guided biopsy: A review of current techniques and applications. J Magn Reson Imaging 2008;27:311-25. (Pubitemid 351222537)
16. Arber DA, George TI. Bone marrow biopsy involvement by non- Hodgkin's lymphoma: Frequency of lymphoma types, patterns, blood involvement, and discordance with other sites in 450 specimens. Am J Surg Pathol 2005;29:1549-57.
17. EL Bolkainy TMN, Abo Deif WS, Gouda HM, Mokhtar NM. Evaluation of bone marrow in 143 lymphomas: The relative frequency and pattern of involvement, secondary myelopathies, pitfalls and diagnostic validity. J Egypt Natl Canc Inst 2008;20:17-30.
18. Levis A, Pietrasanta D, Godio L, Vitolo U, Ciravegna G, Di Vito F, et al. A large-scale study of bone marrow involvement in patients with Hodgkin's lymphoma. Clin Lymphoma 2004;5:50-5. (Pubitemid 39136443)
19. Moid F, DePalma L. Comparison of relative value of bone marrow aspirates and bone marrow trephine biopsies in the diagnosis of solid tumor metastasis and Hodgkin lymphoma: Institutional experience and literature review. Arch Pathol Lab Med 2005;129:497-501. (Pubitemid 40471196)
20. Döbert N, Menzel C, Berner U, Hamscho N, Wördehoff N, Mitrou P, et al. Positron emission tomography in patients with Hodgkin's disease: Correlation to histopathologic subtypes. Cancer Biother Radiopharm 2003;18:565-71. (Pubitemid 37082376)
21. Goethals I, Hoste P, De Vriendt C, Smeets P, Verlooy J, Ham H. Time-dependent changes in 18F-FDG activity in the thymus and bone marrow following combination chemotherapy in paediatric patients with lymphoma. Eur J Nucl Med Mol Imaging 2010;37:462-7.